Literature DB >> 19250943

Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle.

Zhengshan Zhao1, Yong-Jik Lee, Soo-Kyung Kim, Hae-Jin Kim, Wan-Sub Shim, Chul-Woo Ahn, Hyun-Chul Lee, Bong-Soo Cha, Zhongmin Alex Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19250943      PMCID： PMC2905871          DOI： 10.1016/j.lfs.2009.02.021

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  41 in total

1.  Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.

Authors:  Blake B Rasmussen; Ulf C Holmbäck; Elena Volpi; Beatrice Morio-Liondore; Douglas Paddon-Jones; Robert R Wolfe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Management of cellular energy by the AMP-activated protein kinase system.

Authors:  D Grahame Hardie; John W Scott; David A Pan; Emma R Hudson
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

Review 3.  AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.

Authors:  Neil Ruderman; Marc Prentki
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

4.  Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart.

Authors:  K G Thampy
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

5.  Determination of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography.

Authors:  M T King; P D Reiss; N W Cornell
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

6.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

7.  Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.

Authors:  D Chien; D Dean; A K Saha; J P Flatt; N B Ruderman
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-08       Impact factor: 4.310

8.  Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.

Authors:  Asish K Saha; Paco R Avilucea; Ji Ming Ye; Murwarid M Assifi; Edward W Kraegen; Neil B Ruderman
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

Review 9.  Malonyl-CoA and AMP-activated protein kinase: an expanding partnership.

Authors:  Asish K Saha; Neil B Ruderman
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

10.  Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.

Authors:  Gha Young Lee; Nam Hee Kim; Zheng-Shan Zhao; Bong Soo Cha; Yu Sam Kim
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857
View more
  9 in total

1.  Locating the source of hyperglycemia: liver versus muscle.

Authors:  Haoyong Yu; Dequan Zhou; Weiping Jia; ZengKui Guo
Journal:  J Diabetes       Date:  2012-03       Impact factor: 4.006

Review 2.  Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Authors:  Andrea M Vincent; Brian C Callaghan; Andrea L Smith; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

3.  Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation.

Authors:  Zhengshan Zhao; Xu Zhang; Chunying Zhao; Jinwoo Choi; Jieyi Shi; Keying Song; John Turk; Zhongmin Alex Ma
Journal:  Endocrinology       Date:  2010-05-12       Impact factor: 4.736

4.  Lysine malonylation is elevated in type 2 diabetic mouse models and enriched in metabolic associated proteins.

Authors:  Yipeng Du; Tanxi Cai; Tingting Li; Peng Xue; Bo Zhou; Xiaolong He; Peng Wei; Pingsheng Liu; Fuquan Yang; Taotao Wei
Journal:  Mol Cell Proteomics       Date:  2014-11-23       Impact factor: 5.911

5.  Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.

Authors:  Enas A Abd El-Haleim; Ashraf K Bahgat; Samira Saleh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 6.  Role of the malonyl-CoA synthetase ACSF3 in mitochondrial metabolism.

Authors:  Caitlyn E Bowman; Michael J Wolfgang
Journal:  Adv Biol Regul       Date:  2018-09-05

7.  Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.

Authors:  Guanghua Luo; Yuehua Feng; Jun Zhang; Qinfeng Mu; Yuanping Shi; Li Qin; Lu Zheng; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Ning Xu
Journal:  Int J Med Sci       Date:  2014-07-29       Impact factor: 3.738

8.  Identification of histone malonylation in the human fetal brain and implications for diabetes-induced neural tube defects.

Authors:  Qin Zhang; Tanxi Cai; Zonghui Xiao; Dan Li; Chunlei Wan; Xiaodai Cui; Baoling Bai
Journal:  Mol Genet Genomic Med       Date:  2020-07-15       Impact factor: 2.183

Review 9.  Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity.

Authors:  Ben Stocks; Juleen R Zierath
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.